MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SHOEMAN, D. W.
Right arrow Articles by MANNERING, G. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by SHOEMAN, D. W.
Right arrow Articles by MANNERING, G. J.

Molecular Pharmacology, Vol 9, 372-382, Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics

Induction of Drug Metabolism

VII. Differences in P-420 Hemoproteins from Untreated and 3-Methylcholanthrene-Treated Rats

D. W. SHOEMAN 1, FLOIE M. VANE 1, and G. J. MANNERING 1

1 Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455

Cytochromes P-450 and P1-450 (P-448), found predominantly in hepatic microsomes from untreated and from 3-methylcholanthrene-treated rats, respectively, are reported to be distinct molecular entities. To test this hypothesis, a comparison was made of soluble P-420 hemoproteins obtained from membrane-bound P-450 hemoproteins by digesting microsomes with steapsin. Partially purified, soluble cytochromes P-420 and P1-420 from microsomes from untreated and 3-methylcholanthrene-treated rats, respectively, were found to differ in their electrophoretic mobilities and in the molar absorbances of their carbon monoxide complexes (P-420, 110 mM-1 cm-1; P1-420, 134 mM-1 cm-1); when caused to aggregate, cytochrome P-420 exhibited both type I (hexobarbital) and type II (aniline difference spectra, but aggregated cytochrome P1-420 exhibited a type II difference spectrum only. That cytochrome P1-450 is not simply a complex of cytochrome P-450 with 3-methylcholanthrene or its metabolites was demonstrated by the failure of soluble, purified cytochrome P1-420 from rats treated with tritiated 3-methylcholanthrene to exhibit radioactivity. These studies support the view that cytochromes P-450 and P1-450 are distinct molecular entities.

Submitted on August 30, 1972







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics